# Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites

> **NCT01082341** · PHASE1,PHASE2 · COMPLETED · sponsor: **Malaria Vaccine and Drug Development Center** · enrollment: 27 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** Immunization with P. vivax irradiated sporozoites

## Key facts

- **NCT ID:** NCT01082341
- **Lead sponsor:** Malaria Vaccine and Drug Development Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-05
- **Final completion:** 2017-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082341, "Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01082341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*